PULMONARY SARCOIDOSIS
Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY SARCOIDOSIS trials appear
Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to tame sarcoidosis, cut steroid dependence
Disease control Recruiting nowThis study is testing a new drug called XTMAB-16 for adults with pulmonary sarcoidosis. The main goals are to see if the drug is safe and if it can help patients reduce their dose of steroid medications like prednisone. Participants will receive the study drug while trying to low…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill targets lung inflammation in sarcoidosis
Disease control Recruiting nowThis study is testing whether a new oral drug called OATD-01 can help control active lung sarcoidosis. About 96 adults with symptomatic lung sarcoidosis will take either the drug or a placebo pill for 12 weeks. Researchers will use special scans to see if the drug reduces lung in…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists hunt for genetic clues behind common lung diseases
Knowledge-focused Recruiting nowThis study aims to understand how genetic factors contribute to the development of various lung diseases, including cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will enroll 3,500 participants, both with and without lung conditions, to examine their genes and compa…
Matched conditions: PULMONARY SARCOIDOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Apr 04, 2026 01:35 UTC